{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:36:22Z","timestamp":1791426982785,"version":"4.3.3"},"reference-count":17,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jiac.2024.06.011","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T16:03:56Z","timestamp":1718813036000},"page":"1289-1294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phase III, open-label, single-arm study of a new MMR vaccine (JVC-001); measles AIK-C, mumps RIT 4385, rubella Takahashi, as a second vaccine dose in healthy Japanese children aged 5\u20136 years"],"prefix":"10.1016","volume":"30","author":[{"given":"Tetsuo","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-0929","authenticated-orcid":false,"given":"Yoshitaka","family":"Sogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Nakatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoshi","family":"Kimata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Oe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2024.06.011_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(95)92311-X","article-title":"Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan","volume":"346","author":"Ueda","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2024.06.011_bib2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archpedi.1990.02150320069030","article-title":"A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies","volume":"144","author":"Makino","year":"1990","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jiac.2024.06.011_bib3","series-title":"Changes in the immunization schedule recommended by the Japan Pediatric Society","year":"2020"},{"key":"10.1016\/j.jiac.2024.06.011_bib4","first-page":"259","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"64","author":"McLean","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jiac.2024.06.011_bib6","first-page":"33","article-title":"Recommendation of the Advisory Committee on Immunization Practices for use of a third dose of mumps virus\u2013containing vaccine in persons at increased risk for mumps during an outbreak","volume":"67","year":"2018","journal-title":"MMWR"},{"key":"10.1016\/j.jiac.2024.06.011_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/14760584.2018.1445529","article-title":"Waning immunity of one-dose measles-mumps-rubella vaccine to mumps in children from kindergarten to early school age: a prospective study","volume":"17","author":"Liu","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jiac.2024.06.011_bib8","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1016\/j.vaccine.2021.05.008","article-title":"Waning immunity and potential asymptomatic infection in 3-7 years old children who received one dose of measles-mumps-rubella vaccine: a 4-year prospective study","volume":"39","author":"Liu","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2024.06.011_bib9","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2165\/00003495-200363190-00012","article-title":"Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella","volume":"63","author":"Wellington","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.jiac.2024.06.011_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/00365540110026593","article-title":"Immunogenicity and reactogenicity of a new measles, mumps and rubella vaccine when administered as a second dose at 12 y of age","volume":"33","author":"Gothefors","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jiac.2024.06.011_bib11","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1080\/21645515.2018.1554971","volume":"15","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jiac.2024.06.011_bib12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/INF.0000000000003111","article-title":"Effectiveness of \"Priorix\" against measles and mumps diseases in children born after 2004 in the United Kingdom: a retrospective case-control study using the clinical practice research datalink GOLD database","volume":"40","author":"Povey","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2024.06.011_bib13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/21645515.2019.1578591","article-title":"Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I\/II clinical trial","volume":"15","author":"Nakayama","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jiac.2024.06.011_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jviromet.2007.01.001","article-title":"Development of a new neutralization test for measles virus","volume":"142","author":"Fujino","year":"2007","journal-title":"J Virol Meth"},{"key":"10.1016\/j.jiac.2024.06.011_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7883\/yoken.JJID.2015.162","article-title":"Persistence of immunity acquired after a single dose of rubella vaccine in Japan","volume":"69","author":"Okafuji","year":"2016","journal-title":"Jpn J Infect Dis"},{"issue":"2","key":"10.1016\/j.jiac.2024.06.011_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-0934(99)00019-1","article-title":"Assay of humoral immunity to mumps virus","volume":"79","author":"Pipkin","year":"1999","journal-title":"J Virol Meth"},{"key":"10.1016\/j.jiac.2024.06.011_bib17","article-title":"A randomized comparative study of a new measles, mumps and rubella (MMR) vaccine with a widely used MMR vaccine administered as a second dose at 4-6 years of age [abstract no. p-37 plus poster]","author":"Arguedas","year":"2000","journal-title":"18th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID)"},{"issue":"5","key":"10.1016\/j.jiac.2024.06.011_bib18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10156-013-0641-6","article-title":"Vaccine chronicle in Japan","volume":"19","author":"Nakayama","year":"2013","journal-title":"J Infect Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24001661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24001661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:56:40Z","timestamp":1738717000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24001661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1341321X24001661"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.06.011","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase III, open-label, single-arm study of a new MMR vaccine (JVC-001); measles AIK-C, mumps RIT 4385, rubella Takahashi, as a second vaccine dose in healthy Japanese children aged 5\u20136 years","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}